CNC · Centene Corporation
$63.41
-0.27% last session
End-of-day data · updated 2026-07-28
Market cap
$32B
Enterprise value
$24B
Trailing P/E
—
Forward P/E
14.3
Dividend yield
—
Beta
1.08
Avg volume
6M
Employees
61K
2D change
—
5D change
0.53%
10D change
-3.55%
30D change
-2.51%
60D change
7.52%
MTD change
-6.25%
YTD change
55.72%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — CNC
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-14
Latest call per bank · past 12 months
Wells Fargo
Equal-Weight$69.00
+8.8% vs priceRBC Capital
Sector Perform$71.00
+12.0% vs priceJP Morgan
Neutral$60.00
-5.4% vs priceBank of America
Buy$74.00
+16.7% vs priceMorgan Stanley
Equal-Weight$57.00
-10.1% vs priceBarclays
Overweight$75.00
+18.3% vs priceUBS
Neutral$61.00
-3.8% vs priceDeutsche Bank
Buy$80.00
+26.2% vs priceJefferies
Hold$39.00
-38.5% vs priceGoldman Sachs
Sell$38.00
-40.1% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-14 | TD Cowen | Maintains | Hold | $47.00 → $65.00 |
| 2026-07-14 | Truist Securities | Maintains | Buy | $71.00 → $78.00 |
| 2026-07-13 | Wells Fargo | Maintains | Equal-Weight | $56.00 → $69.00 |
| 2026-07-09 | RBC Capital | Maintains | Sector Perform | $70.00 → $71.00 |
| 2026-07-07 | Cantor Fitzgerald | Maintains | Overweight | $60.00 → $75.00 |
| 2026-06-23 | RBC Capital | Initiates | Sector Perform | $0.00 → $70.00 |
| 2026-06-08 | Mizuho | Maintains | Neutral | $58.00 → $63.00 |
| 2026-06-08 | JP Morgan | Maintains | Neutral | $52.00 → $60.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 47 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 0.8% above the 50-day MA ($63.43).
- Price vs 200-day MA: Trading 38.3% above the 200-day MA ($46.22).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.65) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($25.21) and high ($68.72).
CNC Price Chart
Loading chart for CNC…
Fundamentals
About Centene Corporation
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
More in Healthcare Plans
UNH
UnitedHealth Group Incorporated
$379B 28.2% YTD
CVS
CVS Health Corporation
$137B 38.1% YTD
ELV
Elevance Health, Inc.
$82B 9.0% YTD
CI
The Cigna Group
$77B 6.9% YTD
MOH
Molina Healthcare Inc
$10B 14.9% YTD
OSCR
Oscar Health, Inc.
$9B 97.2% YTD
ALHC
Alignment Healthcare, Inc.
$4B -5.5% YTD
PGNY
Progyny, Inc.
$2B 23.0% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.